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Background: Uncoupling protein 2 (UCP2) gene polymorphisms have been reported as genetic risk factors for
obesity and type 2 diabetes mellitus (T2DM). We examined the association of commonly observed UCP2 G(−866)A
(rs659366) and Ala55Val (C> T) (rs660339) single nucleotide polymorphisms (SNPs) with obesity, high fasting plasma
glucose, and serum lipids in a Balinese population.
Methods: A total of 603 participants (278 urban and 325 rural subjects) were recruited from Bali Island, Indonesia.
Fasting plasma glucose (FPG), triglyceride (TG), high density lipoprotein cholesterol (HDL-C), low density lipoprotein
cholesterol (LDL-C) and total cholesterol (TC) were measured. Obesity was determined based on WHO classifications
for adult Asians. Participants were genotyped for G(−866)A and Ala55Val polymorphisms of the UCP2 gene.
Results: Obesity prevalence was higher in urban subjects (51%) as compared to rural subjects (23%). The genotype,
minor allele (MAF), and heterozygosity frequencies were similar between urban and rural subjects for both SNPs. All
genotype frequencies were in Hardy-Weinberg equilibrium. A combined analysis of genotypes and environment
revealed that the urban subjects carrying the A/A genotype of the G(−866)A SNP have higher BMI than the rural
subjects with the same genotype. Since the two SNPs showed strong linkage disequilibrium (D’= 0.946, r2 = 0.657), a
haplotype analysis was performed. We found that the AT haplotype was associated with high BMI only when the
urban environment was taken into account.
Conclusions: We have demonstrated the importance of environmental settings in studying the influence of the
common UCP2 gene polymorphisms in the development of obesity in a Balinese population.
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Obesity and type 2 diabetes mellitus (T2DM) have be-
come global health concerns. The International Obesity
Task Force estimated that approximately one billion
adults are overweight, and 475 million of them are obese
[1]. In 2010, it was predicted that 285 million people
might suffer from T2DM worldwide [2]. Obesity and
T2DM would eventually develop into metabolic disor-
ders and coronary heart disease (CHD), in particular
when accompanied with a high serum lipid level. The
rapidly increasing prevalence of obesity and T2DM, as
well as a high serum lipid level were markedly noticed in
developing countries, proposed to be the result of* Correspondence: ina@eijkman.go.id
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distribution, and reproduction in any mediumadopting a Western lifestyle, and characterized by
increased consumption of energy-dense food and
reduced physical activity [3,4].
Obesity and T2DM manifested from a combination of
genetic predispositions and unfavorable environmental
factors, involving unbalanced energy intake and expendi-
tures for basal metabolic process and physical activity
[5,6]. One of the key regulators of energy balance is the
uncoupling protein 2 (UCP2), a transporter protein
present in the mitochondrial inner membrane (UniProt
accession P55851) [7]. UCP2 mediates proton leak across
the inner membrane via uncoupling of the substrate oxi-
dation from ATP synthesis, thus decreasing ATP produc-
tion by mitochondrial respiratory chain. Consequently,
UCP2 activity may suppress glucose-stimulated insulin
secretion, which is regulated by the ATP/ADP ratio [8,9].tral Ltd. This is an Open Access article distributed under the terms of the
creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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pression of UCP2 was associated with reduced insulin
secretion [10,11]. The effect of UCP2 on insulin secre-
tion has been reported to extend towards regulation of
fat metabolism, either directly or indirectly [12], by pro-
moting fat oxidation [13]. In response to fasting, UCP2
was reported to promote degradation of triacylglycerols
[14] and fatty acid oxidation by limiting glycolysis [15].
Other reports showed that UCP2 expression appeared to
be up-regulated in response to a high fat diet [12,16,17].
Taken together, these reports suggest that UCP2 has a
role in counteracting diet-induced obesity by enhancing
peripheral fatty acid metabolism.
The commonly observed UCP2 gene single nucleotide
polymorphisms (SNPs) G(−866)A in the promoter region
(rs659366) and Ala55Val (a C to T substitution) in exon 4
(rs660339) have been associated with obesity and T2DM
to a certain degree. The G(−866)A has been shown to
affect the UCP2 expression level, since this mutation is
located within the cis regulatory region that interacts with
multiple nuclear trans activating factors [18]. The minor
allele was correlated with reduced obesity risk [19]. In vari-
ous ethnicities, the UCP2 G(−866)A SNP has also been
associated with central obesity [20], hyperinsulinemia in
obese subjects [21], and increased or decreased risk of
CHD [22-24]. Other reports have associated the A allele
with increased levels of HDL-C and decreased levels of
LDL-C in a Chinese population [25], and reduced LDL
particle size levels [26]. The 55Val/Val genotype of the
Ala55Val polymorphism was reported to be associated
with a higher incidence of T2DM in Caucasians and Afri-
can-Americans [27], similar to our previous study in a lim-
ited Balinese urban population [28]. This variant also
showed an association with a higher fasting insulin level in
obese Taiwanese aborigines [29]. Studies on metabolic rate
measurement have found a lower 24-h energy expenditure
[30] and a higher efficiency of energy exercises [31] in sub-
jects carrying 55Val/Val. Thus, people with this genotype
would have more efficient energy use due to a lower de-
gree of uncoupling, resulting in the increased ATP and re-
active oxygen species (ROS) production [8].
In this study, we aim to examine the association of the
UCP2 gene G(−866)A and Ala55Val SNPs with obesity,
high FPG and serum lipids in a Balinese population, which
has not been characterized for the SNPs, comparing the
urban and rural population. Apart from our previous re-
port in a limited Balinese urban population [28], there was
no other report on the association of these SNPs with
obesity, high FPG and serum lipids in the Balinese. Bali-
nese people have been exposed to lifestyle changes
brought by tourism development in the last two decades.
We propose that the effect of these changes, reflected by
the high prevalence of subjects with obesity, high FPG,
and serum lipids disorder, was modulated by UCP2 SNPs.Materials and methods
Subjects and study design
A cross-sectional study was conducted, enrolling 603
random participants from Bali, Indonesia, with informed
consent (ethical approval was granted from the Faculty
of Medicine Ethic Committee, Udayana University, and
the Eijkman Institute Research Ethics Commission) [32].
This study was part of the metabolic disorder study done
in Bali, where DNA samples were available [33]. The
subjects were recruited by random sampling from either
urban (278 subjects) or rural (325 subjects) settlements,
and then stratified for large villages and sub-villages.
Mean of subjects’ age is 46 ± 10 years and 52 ± 16 for
urban and rural populations, respectively.
Measurements
Anthropometric measurements were taken, including
body mass index (BMI) which was calculated as body
weight in kilograms divided by the square of height in
meters. Study subjects were classified as obese (BMI
≥25 kg/m2) according to the Asia-Pacific perspective re-
defining obesity in adult Asian [34]. It has been reported
that higher metabolic risks were observed in Asian at a
given BMI as compared to Caucasian, proposed to be
due to the interplay of genetic susceptibility and environ-
mental factors [35].
Blood samples were drawn after at least 10 hours over-
night fasting. Fasting plasma glucose (FPG) was mea-
sured using the standard hexokinase method. High FPG
of ≥126 mg/dL was determined based on the WHO
recommendations [36]. To determine the fasting serum
lipids, standard spectrophotometric methods were
employed. The examined fasting lipid profiles were tri-
glycerides (TG), high density lipoprotein cholesterol
(HDL-C), low density lipoprotein cholesterol (LDL-C)
and total cholesterol (TC). Classifications of TG, HDL-C,
LDL-C, and TC were based on The National Cholesterol
Education Program (NCEP)-Adult Treatment Panel III
(ATPIII) guidelines on detection, evaluation, and treat-
ment of high blood cholesterol in adults [37]. Classifica-
tions of TG were: normal <150 mg/dL; borderline 150–
199 mg/dL; high 200–499 mg/dL; very high ≥500 mg/dL.
Classifications of HDL-C were: low <40 mg/dL; normal
40–59 mg/dL; high ≥60 mg/dL. Classifications of LDL-C
were: optimal <100 mg/dL; near optimal 100–129 mg/
dL; borderline high 130–159 mg/dL; high 160–189 mg/
dL; very high≥ 190 mg/dL. Classifications of TC were:
desirable <200 mg/dL; borderline high 200–239 mg/dL;
high ≥240 mg/dL [37].
DNA Extraction and Genotyping
Genomic DNA was extracted from blood spots in
Guthrie Cards (Whatman, Clifton, NJ, USA) using a
Chelex-100 (Bio-Rad, Hercules, CA, USA) protocol [38],
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out method [39]. SNPs detections were performed by
polymerase chain reaction-restriction fragment length
polymorphisms (PCR-RFLP) method, as described previ-
ously by Sesti et al. for the G(−866)A polymorphism [40]
and Kubota et al. for the Ala55Val polymorphism [41].
In brief, a DNA fragment corresponding to the UCP2 G
(−866)A polymorphism (rs659366) was amplified by 5’-
CACGCTGCTTCTGCCAGGAC-3’ as forward primer
and 5’-AGGCGTCAGGAGATGGACCG-3’ as reverse
primer [40]. PCR products were digested by MluI restric-
tion enzyme (NEB, Ipswich, MA, USA) and separated on
2% agarose gel electrophoresis. The (−866)AA genotype
was marked by a single 363 bp fragment due to lost of
MluI site, while the wild-type (−866)GG genotype was
digested into 295 bp and 68 bp fragments. For the
Ala55Val polymorphism (rs660339), a DNA fragment
was amplified using a pair of oligonucleotide primer
containing mismatched bases: forward primer 5'-CTG
GAGTCTCGATGGTGTCTAC-3', and reverse primer 5'-
CACCGCGGTACTGGGCGTTG-3' that possessed a
HincII site [41]. The 198 bp PCR products were digested
with HincII (NEB, Ipswich, MA, USA), the Val55Val
genotype was marked by the presence of the HincII site,
resulting in two DNA fragments of 179 bp and 19 bp
which were subjected to 3% agarose gel electrophoresis
(Lonza, Basel, Switzerland).
Statistical Analyses
The data exploration and analysis was performed by util-
izing custom scripts for data preprocessing and R statis-
tical packages employing genetics, rms and haplo.stats
libraries. Continuous variables were shown as mean± SD
and compared by performing the Welch’s t-test for vari-
ables with normal distribution or the Mann–Whitney U-
test for variables with skewed distribution. Departure of
the genotype distribution to Hardy-Weinberg equilib-
rium was determined using the Fisher’s exact test. Link-
age disequilibrium was measured using D’ and r2
statistics as implemented in the genetics library. We con-
sidered p-values of less than 0.05 as significant. The p-
values for genotype frequency of each SNP between
urban and rural population were calculated using Fisher’s
exact test on 2 × 3 contingency table.
In order to determine the association between UCP2
genotypes and disease traits, multiple ordinal logistic
regressions were conducted with adjustment for age,
gender and environment (urban vs. rural). The logistic
regressions were performed as implemented in the rms
library from R statistical packages. All disease traits were
categorized as previously defined, and the associated p-
values were calculated using the Wald test.
The association between UCP2 haplotypes and disease
traits were determined by logistic regressions whichemployed the expectation maximization (EM) algorithm
for determining the haplotypes as implemented in haplo.
glm function of haplo.stats library from R statistical
packages. Both the additive and dominant models of
genetic effects were considered for the analysis, with
adjustments for age, gender and population. The reces-
sive model was not feasible for an analysis due to a very
low frequency of predicted samples that possesses the
rare recessive haplotype. The use of logistic regressions
using the expectation maximization (EM) algorithm was
described in detail elsewhere [42-44].
Results
Baseline characteristics
The baseline characteristics of study subjects (278 urban
and 325 rural Balinese) were listed in Table 1. The over-
all prevalence of obesity (BMI> 25 kg/m2) was 51% in
urban (58% in male, 40% in female), and 23% in rural
(24% in male, 22% in female) subjects. In the non-obese
group, the urban subjects (both male and female)
showed significantly higher BMI as compared to the
rural subjects (all p< 0.001). The rural females have
higher FPG level compared to the urban females
(p= 0.005), although the level was much below the
hyperglycemia limit of 126 mg/dL. In the obese group,
the rural Balinese showed higher TC level than their
urban counterparts (p= 0.025), specifically in males
(p= 0.039).
Genotypic and allelic distributions
The genotype, minor allele (MAF), and heterozygosity
frequencies were moderately equal between urban and
rural subjects for all SNPs, both in non-obese and obese
group, except for the Ala55Val polymorphism of the
non-obese subjects – particularly in males (Table 2). All
of the observed genotype frequencies were in Hardy-
Weinberg equilibrium (p= 0.114 for G(−866)A and
p= 0.477 for Ala55Val in all; p= 0.711 for G(−866)A and
p= 0.681 for Ala55Val in urban; p= 0.091 for G(−866)A
and p= 0.240 for Ala55Val in rural). The G(−866)A
(rs659366) and Ala55Val (rs660339) showed strong link-
age disequilibrium with D’= 0.946 (0.914 for urban and
0.969 for rural subjects) and r2 = 0.657 (0.558 for urban
and 0.743 for rural subjects).
Association of genotypes with disease traits
Logistic regressions analyses were performed to test the
association of the genotypes of each SNPs with high BMI
and increasing levels of FPG, TG, LDL-C, and TC, as well
as decreasing level of HDL-C (Table 3). Although we did
not find any association between genotypes and disease
traits after the analyses were adjusted for age, gender, and
environment (urban/rural), in a combined analysis of gen-
otypes and environment, the urban subjects carrying the
Table 1 Baseline characteristics of study subjects
Variable Non-Obese Obese
Urban Rural p Urban Rural p
All, n 136 250 142 75
Age 46.0 ± 10.9 52.3 ± 16.8 < 0.001 46.3 ± 9.3 49.1 ± 11.5 0.073
FPG 95.2 ± 25.2 97.1 ± 18.9 0.426 99.9 ± 43.7 94.9 ± 11.8 0.204
BMI 22.4 ± 1.9 20.7 ± 2.6 < 0.001 28.6 ± 3.5 27.9 ± 2.1 0.063
TGα 126.4 ± 63.7 118.5 ± 53.8 0.344 160.1 ± 74.6 156.6 ± 69.8 0.882
HDL-Cα 53.2 ± 11.4 54.2 ± 13.9 0.698 48.1 ± 10.6 51.0 ± 9.8 0.054
LDL-C 119.6 ± 34.3 120.6 ± 29.6 0.781 119.4 ± 31.7 126.8 ± 34.9 0.127
TC 198.1 ± 38.2 196.3 ± 34.8 0.638 199.5 ± 36.1 211.0 ± 35.3 0.025
Male, n 72 128 100 40
Age 46.7 ± 11.8 51.1 ± 17.0 0.033 46.1 ± 9.6 49.5 ± 10.7 0.088
FPG 100.4 ± 30.4 98.2 ± 22.9 0.583 94.8 ± 24.9 96.1 ± 14.4 0.701
BMI 22.4 ± 1.7 20.8 ± 2.3 < 0.001 28.9 ± 3.7 28.2 ± 2.2 0.212
TGα 140.2 ± 60.0 127.6 ± 54.3 0.125 176.5 ± 75.2 169.1 ± 62.4 0.735
HDL-Cα 50.1 ± 10.3 49.8 ± 11.2 0.850 44.7 ± 9.1 47.1 ± 7.7 0.113
LDL-C 123.2 ± 34.7 118.3 ± 29.3 0.487 122.2 ± 31.6 131.9 ± 33.8 0.126
TC 201.4 ± 37.9 191.5 ± 34.7 0.068 202.2 ± 36.6 216.6 ± 36.0 0.039
Female, n 64 122 42 35
Age 45.4 ± 9.8 53.6 ± 16.5 < 0.001 46.7 ± 8.5 48.6 ± 12.6 0.452
FPG 89.3 ± 16.1 96.1 ± 13.6 0.005 112.2 ± 69.5 93.6 ± 7.9 0.094
BMI 22.4 ± 2.2 20.6 ± 2.9 < 0.001 28.1 ± 3.0 27.6 ± 1.9 0.364
TGα 110.8 ± 64.6 108.9 ± 51.7 0.500 121.2 ± 57.6 142.2 ± 75.7 0.265
HDL-Cα 56.7 ± 11.7 58.7 ± 15.1 0.472 56.3 ± 9.2 55.5 ± 10.2 0.612
LDL-C 115.6 ± 33.7 123.0 ± 29.8 0.139 112.7 ± 30.6 121.0 ± 35.7 0.279
TC 194.4 ± 38.5 201.3 ± 34.3 0.231 193.1 ± 34.4 204.9 ± 33.9 0.137
Criteria: Obese BMI ≥25 kg/m2 [34], High FPG (≥126 mg/dL) [36], high TG (>200 mg/dL), low HDL-C (<40 mg/dL), high LDL-C (≥ 160 mg/dL), high TC (≥240 mg/dL)
[37]. Data were presented as means ± SD. Statistical comparisons were calculated between the urban and rural populations in each category, continuous variables
were compared using the Welch’s t-test, α Due to skew data distribution, comparisons of TG and HDL were calculated using Mann–Whitney U-test. Significant p
values were in bold.
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the rural subjects carrying the same genotype.
For the Ala55Val polymorphism, there was no associ-
ation of all genotypes (C/C, C/T, or T/T) with disease
traits, but more urban than rural subjects with C/T
genotype (Ala55Val) has higher BMI. Although not sta-
tistically significant, the urban subjects with T/T geno-
type correspondingly showed a tendency for having a
higher BMI than their rural counterparts, marked by
high estimation value of 0.70.
Despite the nonexistent trend in genotypes, we found
that increasing level of FPG, LDL-C and TC was influ-
enced by age. While HDL-C level was lower, BMI and
TG level was higher in male than female subjects. Con-
sistent with our previous observation in non-obese sub-
jects, we found that urban subjects have higher BMIthan rural subjects, suggesting the influence of environ-
mental factors.
Association of UCP2 haplotypes with disease traits
Since the two SNPs studied were in strong linkage disequi-
librium (D’=0.946 and r2 = 0.657), we therefore conducted
logistic regressions to assess the association between hap-
lotypes and the disease traits adjusted for the subject’s age,
gender and environment (urban/rural). Frequencies of all
possible haplotypes were determined by the expectation
maximization (EM) algorithm, and only haplotypes with a
frequency above 5% were taken for further analysis. The
haplotype consisting both of the major allele GC ((−866)
G-55Ala) was the most common (56%), followed by the
haplotype consisting both of the minor allele AT ((−866)
A-55Val) (34%), and AC ((−866)A-55Ala) (8%). The
Table 2 Genotypic and allelic distributions of rs659366 and rs659366 in non-obese and obese subjects
Variables All Male Female
Urban Rural p Urban Rural p Urban Rural p
Non Obese n 136 250 72 128 64 122
G(−866)A (rs659366)
G/G 0.40 0.29 0.065 0.36 0.23 0.055 0.45 0.34 0.177
G/A 0.46 0.53 0.54 0.56 0.36 0.50
A/A 0.14 0.18 0.10 0.20 0.19 0.16
MAF (−866)A 0.37 0.45 0.37 0.48 0.37 0.41
Heterozygosity 0.47 0.50 0.47 0.50 0.47 0.48
A55V (rs660339)
C/C 0.53 0.39 0.033 0.50 0.34 0.029 0.56 0.44 0.265
C/T 0.36 0.43 0.42 0.45 0.30 0.41
T/T 0.11 0.18 0.08 0.20 0.14 0.15
MAF 55Val 0.29 0.39 0.29 0.43 0.29 0.35
Heterozygosity 0.41 0.48 0.42 0.49 0.41 0.46
Obese n 142 75 100 40 42 35
G(−866)A (rs659366)
G/G 0.27 0.29 0.585 0.28 0.28 0.968 0.24 0.31 0.151
G/A 0.54 0.57 0.54 0.52 0.55 0.63
A/A 0.19 0.13 0.18 0.20 0.21 0.06
MAF (−866)A 0.46 0.42 0.45 0.46 0.49 0.37
Heterozygosity 0.50 0.49 0.50 0.50 0.51 0.47
A55V (rs660339)
C/C 0.38 0.41 0.513 0.40 0.40 0.227 0.33 0.43 0.685
C/T 0.54 0.47 0.52 0.42 0.57 0.51
T/T 0.08 0.12 0.08 0.18 0.10 0.06
MAF 55Val 0.35 0.35 0.34 0.39 0.38 0.31
Heterozygosity 0.46 0.46 0.45 0.48 0.48 0.44
Obese criteria: BMI ≥25 kg/m2 [34]. Statistical comparisons were calculated between the urban and rural populations in each category: genetic profiles were
compared using Fisher’s exact test on 2x3 contingency table. Significant p values were in bold.
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thus excluded from the analysis.
In Table 4, we presented the analyses for the additive
and dominant genetic models, except the recessive
model that not feasible to be analyzed due to the low fre-
quency of recessive haplotype GT. The general outcomes
of the additive and dominant models were in parallel.
There was no association of any haplotype with the dis-
eases traits, except when influenced with the urban envir-
onment, as indicated by high BMI in urban subjects
carrying the AT haplotype (p-value in additive/dominant
model = 0.032/0.024). However, subjects with the AC
haplotype showed a tendency for high FPG (estimate
values of 0.82 for the additive model, and 0.77 for the
dominant model, respectively). A noticeable trend of high
TG (estimate values of 0.98 for the additive model, 1.04for the dominant model) and low HDL-C estimate values
of 0.97 for the additive model, and 0.89 for the dominant
model) in urban subjects carrying the AC haplotype was
observed, although both models did not produce any sig-
nificant haplotype-environment interaction.
Independent from any haplotype, high FPG was
affected by age, and the male subjects were subjected to
increased tendency for high BMI, high TG and low
HDL-C. Similarly observed in our genotype analyses,
high BMI was induced by urban environment.
Discussion
In the present study of the Balinese population, we
examined the association of two commonly observed
UCP2 gene polymorphisms, the G(−866)A in the pro-
moter region (rs659366) and the Ala55Val in exon 4
Table 3 Association of genotypes with disease traits
G(−866)A (rs659366)
Genotype -Factor BMI FPG TG HDL-C LDL-C TC
Est. p Est. p Est. p Est. p Est. p Est. p
G/A −0.03 0.934 0.28 0.473 0.44 0.157 −0.39 0.136 −0.29 0.220 −0.09 0.702
A/A −0.44 0.305 0.16 0.755 0.26 0.521 −0.36 0.309 −0.31 0.308 −0.21 0.521
Age −0.01 0.245 0.04 <0.001 −0.01 0.084 0.01 0.141 0.01 0.009 0.02 <0.001
Male 0.44 0.016 0.28 0.284 0.91 <0.001 −1.44 <0.001 0.24 0.117 0.20 0.211
Urban 0.69 0.035 0.12 0.806 0.436 0.204 −0.50 0.103 0.06 0.832 0.07 0.795
G/A-urban 0.57 0.161 −0.11 0.853 −0.11 0.782 0.34 0.377 −0.33 0.333 −0.25 0.480
A/A-urban 1.20 0.035 0.58 0.438 −0.28 0.618 0.61 0.236 0.18 0.682 0.23 0.625
Ala55Val (rs660339)
Genotype -Factor BMI FPG TG HDL-C LDL-C TC
Est. p Est. p Est. p Est. p Est. p Est. p
C/T −0.05 0.859 −0.11 0.756 0.46 0.123 −0.19 0.446 −0.11 0.629 0.08 0.737
T/T −0.55 0.195 −0.03 0.945 0.26 0.488 −0.08 0.811 −0.25 0.391 −0.11 0.741
Age −0.01 0.222 0.04 <0.001 −0.01 0.103 0.01 0.133 0.02 0.007 0.02 <0.001
Male 0.43 0.019 0.30 0.254 0.90 <0.001 −1.45 <0.001 0.21 0.158 0.19 0.249
Urban 0.73 0.010 0.04 0.787 0.46 0.113 −0.30 0.268 −0.09 0.701 0.02 0.931
C/T-urban 0.77 0.046 −0.04 0.945 −0.12 0.760 0.11 0.771 −0.04 0.914 −0.09 0.787
T/T-urban 0.70 0.253 0.57 0.452 −0.87 0.167 0.35 0.528 0.35 0.469 0.11 0.826
Logistic regression analyses of genotypes association with disease traits, adjusted for age, gender, and population (urban/rural). Criteria: Obesity (BMI ≥25 kg/m2)
[34], high FPG (≥126 mg/dL) [36], high TG (200–499 mg/dL), low HDL-C (<40 mg/dL), high LDL-C (≥ 160 mg/dL), high TC (≥240 mg/dL) [37]. Significant p values
obtained from Wald test were in bold.
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Uncoupling protein 2 has been reported to play an im-
portant role in the regulation of human energy metabol-
ism, through its functions of proton gradient dissipation,
and uncoupling of respiration from oxidative phosphor-
ylation that consequently converted ATP to heat. Thus,
variations in the UCP2 gene was proposed as potential
modulator of energy balance.
Urban lifestyle affected BMI
This study provided evidence concerning the role of UCP
2 gene polymorphisms in influencing the increasing preva-
lence of obesity. Moreover, this study has the advantage of
being conducted in a relatively homogeneous population
in terms of genetic backgrounds, considering Bali is a
small island, and intermarriage between Balinese with
individuals from other ethnic groups is still relatively un-
common. Also, as a population that has undergone swift
lifestyle changes for the last 20 years due to rapid develop-
ments in the tourism industry, the traditional Balinese has
become more sedentary [28,32,33]. The effect of these life-
style changes is reflected by the high prevalence of obesity
in the urban as compared to the rural Balinese. Further-
more, BMI was higher in the urban subjects (both male
and female) of the non-obese group, showing that lifestyle
changes influenced the increasing BMI.In spite of the fact that this study has a power limitation
for the genetic analyses due to the relatively small sample
size, in particular in the sub-group analyses, we found that
the MAFs for both G(−866)A and Ala55Val SNPs of the
UCP2 genes were rather high, showing that these poly-
morphisms were relatively frequent in this population.
UCP2 G(−866)A influenced the increased of BMI
In the Balinese population studied, we observed that urban
subjects with A/A genotype of the SNP G(−866)A has
higher BMI than rural subjects with the same genotype,
suggesting the important role of the environment. Several
studies have reported that the A-allele or AA genotype is
associated with obesity [22,45]. In a study conducted in
Korean women undergoing a very low-calorie program,
the A/A genotype of this SNP lost less weight than carriers
of the G-allele [46]. Two other studies reported that in
obese children with the A/A genotype the resting energy
expenditure was increased [47], and in Pima Indians the
SNP was associated with increased 24-hour energy
expenditure [48]. A recent study reported a strong effect
of sibutramine on weight and body fat percentage loss in
the combined UCP2 A/A+G/A of the SNP G(−866)A in a
Taiwanese population [49]. Interesting to note that in their
placebo group, the A/A genotype showed the least weight
and fat percentage loss, which was in agreement with a
Table 4 Association of UCP2 haplotypes with disease traits
Additive Model
Haplotype f High BMI High FPG High TG Low HDL-C High LDL-C High TC
Est. p Est. p Est. p Est. p Est. p Est. p
GC 0.56
AC 0.09 −0.05 0.902 0.82 0.280 −0.23 0.696 −0.58 0.325 −0.48 0.461 −0.65 0.315
AT 0.34 −0.21 0.312 0.33 0.444 0.11 0.676 −0.37 0.211 0.00 0.996 0.21 0.379
GT 0.01 NA NA NA NA NA NA NA NA NA NA NA NA
Age −0.01 0.222 0.05 <0.001 −0.02 0.109 0.01 0.335 0.02 0.086 0.01 0.024
Male 0.46 0.013 0.55 0.155 0.80 0.002 −1.89 <0.001 0.22 0.419 0.25 0.310
Urban 0.74 0.013 0.89 0.218 0.10 0.805 0.90 0.053 0.62 0.135 0.46 0.247
AC-urban 0.24 0.643 0.19 0.835 0.98 0.160 0.97 0.191 −0.44 0.612 −0.04 0.960
AT-urban 0.61 0.032 0.18 0.745 −0.04 0.912 0.49 0.228 −0.40 0.329 −0.42 0.261
GT-urban NA NA NA NA NA NA NA NA NA NA NA NA
Dominant Model
Haplotype f High BMI High FPG High TG Low HDL-C High LDL-C High TC
Est. p Est. p Est. p Est. p Est. p Est. p
GC 0.56
AC 0.09 0.05 0.900 0.77 0.341 −0.19 0.761 −0.60 0.336 −0.49 0.465 −0.64 0.337
AT 0.34 −0.14 0.644 0.26 0.701 0.18 0.644 −0.50 0.303 −0.05 0.882 0.28 0.450
GT 0.01 NA NA NA NA NA NA NA NA NA NA NA NA
Age −0.01 0.234 0.05 <0.001 −0.01 0.112 0.01 0.323 0.02 0.100 0.02 0.025
Male 0.46 0.017 0.53 0.168 0.80 0.002 −1.89 <0.001 0.22 0.403 0.25 0.309
Urban 0.67 0.038 1.04 0.155 −0.08 0.852 0.72 0.171 0.54 0.228 0.41 0.341
AC-urban 0.18 0.739 0.09 0.927 1.04 0.146 0.89 0.247 −0.38 0.668 0.00 1.000
AT-urban 0.89 0.024 −0.01 0.987 0.24 0.637 0.34 0.577 −0.33 0.548 −0.46 0.383
GT-urban NA NA NA NA NA NA NA NA NA NA NA NA
Logistic regression analysis for association of UCP2 haplotypes with diseases traits, assuming the additive and dominant genetic models, adjusted for age, gender,
and population (urban/rural). Significant p values from Wald test were in bold. Analysis for a recessive model was not feasible due to low frequency of rare
haplotype (<5%). Criteria: Obesity (high BMI ≥25 kg/m2) [34], High FPG (≥126 mg/dL) [36], high TG (200–499 mg/dL), low HDL-C (<40 mg/dL), high LDL-C (≥
160 mg/dL), high TC (≥240 mg/dL) [37]. f: haplotype frequencies. NA: not available, data were omitted due to low haplotype frequencies (<5%).
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the effect of the UCP2 G(−866)A polymorphism might be
universal, at least for Asian.
Even though marginal, there was also an association of
the Balinese with C/T genotype of the Ala55Val SNP with
high BMI when influenced by the urban environment, but
we failed to detect the same association with subjects pos-
sessing the homozygous risk alleles T/T, which indicates
that the interaction of UCP2 genotypes and environment is
not straightforward.
Although we did not observe any significant association
with other traits, a previous study has reported that sub-
jects with the (−866)A/A genotype had significantly
reduced LDL particle size, a significant predictor of the
development for coronary artery disease, than those with
the (−866)G/G genotype [26]. Several studies have con-
firmed the association of either G(−866)A and/or Ala55Val
variants with T2DM [18,23,25,27,31]. In the obese state,the risk would be increased due to insulin resistance,
which may accompany obesity and impairment of glucose-
stimulated insulin secretion attributable to UCP2 at-risk
genotype [50]. Excess of fat storage in the obesity state
may lead to local insulin resistance, and might stimulate a
chronic, sub-acute state of inflammation. A study reported
an association of the high-sensitivity C reactive protein
(hs-CRP), a biomarker of inflammation that is also a
powerful risk marker for cardiovascular disease, with the
G(−866)A polymorphism, thus suggesting the role of
UCP2 gene in the regulation of the inflammatory response
[51]. The lack of association of individual UCP2 SNPs and
disease traits in the Balinese population might be due to
the influence of other genetic or environmental factors
that were not studied in this research, such as the
MTNR1B gene polymorphism that has been reported to
be associated with type 2 diabetes mellitus and lipid levels
in Han Chinese population [52].
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The G(−866)A and Ala55Val SNPs were in strong linkage
disequilibrium. Therefore, the effect of one SNP cannot be
separated from the other. To address the influence of
combined UCP2 variants on high BMI, high levels of FPG,
TG, LDL-C, and TC, as well as low level of HDL-C, we
generated UCP2 haplotypes and tested the association
between haplotypes and disease traits. Again, we did not
find significant association between haplotypes and traits,
unless influenced by the urban environment. The AT
((−866)A-55Val) haplotype showed an association with
high BMI in urban, in both additive and dominant models.
A trend of high FPG was observed in carriers of AC
((−866)A-55Ala) haplotype. We also noticed a tendencies
of high TG, and low HDL-C in urban subjects carrying the
AC ((−866)A-55Ala) haplotype, although not significant
for haplotype-environment interaction in both models,
which might be due to the low frequency of this haplotype
in the population studied.
In our study, the level of FPG and TC in the Balinese
increased with age, and male subjects have more ten-
dency for high BMI than female subjects. A study con-
ducted in non-diabetic Chinese reported a 0.15 mmol/L
increase in FPG for every decade of increase in age [53].
In a previous study to determine the effects of sex and
ovarian hormones carried out in mice, it was reported
that male mice had a greater susceptibility of body
weight gain than female mice [54].
In this study, we did not find significant association be-
tween UCP2 gene polymorphisms and disease traits. How-
ever, we were able to demonstrate that in an urban
environment, the A/A genotype of the G(−866)A SNP and
the AT haplotype were associated with high BMI, and con-
sequently resulted in high prevalence of obesity. Discrep-
ancies between our results and others might be due not
only to different ethnic groups and genetic makeup, but
also to the influence of various lifestyle and environmental
exposures, as well as the responses to these exposures.
Thus, the role of the UCP2 variants as obesity and/or dia-
betes risk factor might be overshadowed by environmental
influence in some populations. Nonetheless, this study and
others have emphasized the important role of UCP2 in
metabolism, and therefore further investigations are
needed to confirm its specific role.
Conclusions
Our study has provided compelling evidence regarding
the importance of environmental settings in studying the
involvement of UCP2 gene polymorphisms in the devel-
opment of obesity in a Balinese population. We demon-
strated that the UCP2 gene polymorphisms G(−866)A
and Ala55Val are associated with obesity in Balinese, but
only if the urban environment was taken into account.
However, the above interaction appeared nonexclusive,since other genetic or environmental factors that were
not studied in this research might modify the outcome.
Therefore, it is imperative to conduct further studies
using more genetic markers.
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